Implementing reflective multicriteria decision analysis (MCDA) to assess orphan drugs value in the Catalan Health Service (CatSalut)

BACKGROUND: Orphan medicines show some characteristics that hinder the evaluation of their clinical added value. The often low level of evidence available for orphan drugs, together with a high budget impact and an incremental cost-effectiveness ratio many times higher than drugs used for non-orphan...

Descripción completa

Detalles Bibliográficos
Autores principales: Guarga, Laura, Badia, Xavier, Obach, Mercè, Fontanet, Manel, Prat, Alba, Vallano, Atonio, Torrent, Josep, Pontes, Caridad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6598260/
https://www.ncbi.nlm.nih.gov/pubmed/31248421
http://dx.doi.org/10.1186/s13023-019-1121-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6598260/
https://www.ncbi.nlm.nih.gov/pubmed/31248421
http://dx.doi.org/10.1186/s13023-019-1121-6

Ejemplares similares